Skip to main content

Table 3 Lipid profiles of CAD cases and controls according to APOA1 -75 G/A polymorphisms

From: Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease

 

CAD

P value

Controls

P value

GG

GA

AA

GG

GA

AA

TG (mg/dL)

187.1 ± 79.3

198.9 ± 92.5

175.5 ± 86.2

0.72

160.5 ± 57.3

176.1 ± 62.4

156.9 ± 59.8

0.68

TC (mg/dL)

192.4 ± 55.7

206.4 ± 59.4

203.3 ± 56.8

0.44

178.9 ± 48.7

194.8 ± 53.6

191.4 ± 50.2

0.39

HDL-C (mg/dL)

30.4 ± 10.6

36.8 ± 11.9

41.5 ± 12.7

<0.001

37.1 ± 12.0

41.2 ± 13.6

46.8 ± 14.5

<0.001

LDL-C (mg/dL)

124.6 ± 36.9

129.8 ± 40.1

126.7 ± 38.2

0.87

109.7 ± 30.5

118.4 ± 36.5

113.2 ± 33.7

0.69

VLDL-C (mg/dL)

37.4 ± 12.4

39.8 ± 19.7

35.1 ± 10.6

0.31

32.1 ± 17.6

35.2 ± 18.4

31.4 ± 16.2

0.42

ApoA1 (mg/dL)

114.5 ± 20.7

127.6 ± 22.5

138.9 ± 24.1

<0.001

124.4 ± 23.5

135.7 ± 24.3

144.7 ± 25.8

<0.001

ApoB (mg/dL)

86.7 ± 25.4

97.6 ± 29.5

90.7 ± 26.9

0.63

88.1 ± 25.8

93.6 ± 27.5

89.5 ± 26.7

0.74

  1. CAD, coronary artery disease; APOA1, apolipoprotein A1; OR, odds ratio; CI, confidence interval; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very-low-density lipoprotein cholesterol; Apo, apolipoprotein